Peezy Midstream: new evidence at RCOG2018 Annual Congress, Singapore

At the Royal College of Obstetrics and Gynaecology Annual Congress in Singapore last week, Dr Michelle Jie presented her Abstract of results from the The Royal Surrey County Hospital Antenatal trial of Peezy Midstream.
The paper confirms that compared with a historic 15.9% MSUs sent inappropriately for culture, Peezy Midstream technology delivered specimen contamination of just 2.5%, with 70% of patients finding the device user-friendly.
Printable versions of the Abstract and the presentation of the detailed interim analysis of the trial progress which was given at the Forte Medical Forum in 2017 – shown above –  are available on request at hello@forte-medical.com